Acta Scientific Ophthalmology (ISSN: 2582-3191)

Research Article Volume 6 Issue 1

Bio-Reset and Complete Treatment of Chronic Glaucoma Center for General Informational Regenerative Medicine and Ophthalmology

Massimo Lombardi*

Ophthalmologist - Regenerative Medicine Specialist, Lombardi-Eye-Clinic, Rome, Italy

*Corresponding Author: Massimo Lombardi, Ophthalmologist - Regenerative Medicine Specialist, Lombardi-Eye-Clinic, Rome, Italy.

Received: November 30, 2022; Published: December 20, 2022

Abstract

Presentation: It is necessary to “Re-Formulate” -in Toto- “the Clinical Perspective of Glaucoma” since it has been focused “mostly" on the "Control of intra-Ocular Pressure Rise" caused by a "Progressive Increasing Resistance to Water Mood’ Outflow" in "Schlemm's Canal Trabeculate”.

A "Reductive and Myopic Vision of the Problem" which, in fact, has allowed "in the last centuries" "superficial and erroneous -Scientific- Thinking" unable to understand the "True Reasons" and not only the "Consequences" of the well known Clinical Phenomenon, that the Progressive Increase in Ocular Pressure inevitably leads to an inexorably worsening of visual functions as the: Visual Field, Visual Ability and Acuity, Color Vision, Contrast Sensitivity and Night Vision, up to a "Progressive Blindness'".

Keywords: Chronic Glaucoma; Collagen; Lamina Cribrosa

References

  1. Massimo Lombardi. “Retinal Stem Cells Reprogramming". Journal of Ophthalmology and Clinical Research (2018).
  2. Massimo Lombardi. “Retinal Stem Cells Reprogramming Using Homotoxicological Pharmaceuticals Blend Therapy through Retrobulbar Injections". Journal of Stem Cells Research (2018).
  3. Massimo Lombardi. “Retinal and Body' Stem Cells Reprogramming”. Acta Scientific Ophthalmology6 (2021).
  4. Massimo Lombardi. “Biological Reset and Chronic Glaucoma Healing”. Acta Scientific Ophthalmology12 (2021).

Citation

Citation: Massimo Lombardi. “Bio-Reset and Complete Treatment of Chronic Glaucoma Center for General Informational Regenerative Medicine and Ophthalmology".Acta Scientific Ophthalmology 6.1 (2023): 19-28.

Copyright

Copyright: © 2022 Massimo Lombardi. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days
ISI- IF1.042
JCR- IF0.24

Indexed In




News and Events


Contact US